Advertisement
Review Article| Volume 41, ISSUE 3, P405-419, September 2020

Multimorbidity in Patients with Chronic Obstructive Pulmonary Disease

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Chest Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Reference

      1. Affairs DOEAS, Population. United Nations, Department of Economic and Social Affairs, Population Division (2013). World Population Prospects: the 2012 Revision, Highlights and Advance Tables. Working Paper No. ESA/P/WP.228.; 2013.

        • Barnett K.
        • Mercer S.W.
        • Norbury M.
        • et al.
        Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.
        Lancet. 2012; 380: 37-43
        • Martinez F.D.
        Early-life origins of chronic obstructive pulmonary disease.
        N Engl J Med. 2016; 375: 871-878
        • Celli B.R.
        COPD: time to improve its taxonomy?.
        ERJ Open Res. 2018; 4: 1-8
        • Agustí A.
        • Calverley P.M.A.
        • Celli B.
        • et al.
        Characterisation of COPD heterogeneity in the ECLIPSE cohort.
        Respir Res. 2010; 11: 122
        • Celli B.R.
        • Cote C.G.
        • Marin J.M.
        • et al.
        The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
        N Engl J Med. 2004; 350: 1005-1012
        • Divo M.J.
        • Celli B.R.
        • Poblador-Plou B.
        • et al.
        Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: evidence from the epichron cohort.
        PLoS One. 2018; 13: e0193143
        • Naghavi M.
        • Abajobir A.A.
        • Abbafati C.
        • et al.
        Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016.
        Lancet. 2017; 390: 1151-1210
        • McGarvey L.P.
        • John M.
        • Anderson J.A.
        • et al.
        Ascertainment of cause-specific mortality in COPD: operations of the TORCH clinical Endpoint Committee.
        Thorax. 2007; 62: 411-415
        • Sin D.D.
        • Anthonisen N.R.
        • Soriano J.B.
        • et al.
        Mortality in COPD: role of comorbidities.
        Eur Respir J. 2006; 28: 1245-1257
        • Agustí A.
        • Noell G.
        • Brugada J.
        • et al.
        Lung function in early adulthood and health in later life: a transgenerational cohort analysis.
        Lancet Respir Med. 2017; 5: 935-945
        • Divo M.J.
        • Cote C.
        • de Torres J.P.
        • et al.
        Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2012; 186: 155-161
        • Vanfleteren L.E.G.W.
        • Spruit M.A.
        • Groenen M.
        • et al.
        Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2013; 187: 728-735
        • Mapel D.W.
        • Hurley J.S.
        • Frost F.J.
        • et al.
        Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization.
        Arch Intern Med. 2000; 160: 2653-2658
        • Cazzola M.
        • Bettoncelli G.
        • Sessa E.
        • et al.
        Prevalence of comorbidities in patients with chronic obstructive pulmonary disease.
        Respiration. 2010; 80: 112-119
        • van Manen J.G.
        • Bindels P.J.
        • IJzermans C.J.
        • et al.
        Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40.
        J Clin Epidemiol. 2001; 54: 287-293
        • Schnell K.
        • Weiss C.O.
        • Lee T.
        • et al.
        The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008.
        BMC Pulm Med. 2012; 12: 26
        • Putcha N.
        • Han M.K.
        • Martinez C.H.
        • et al.
        Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans.
        Chronic Obstr Pulm Dis. 2014; 1: 105-114
        • Crisafulli E.
        • Costi S.
        • Luppi F.
        • et al.
        Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation.
        Thorax. 2008; 63: 487-492
        • Terzano C.
        • Conti V.
        • Di Stefano F.
        • et al.
        Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study.
        Lung. 2010; 188: 321-329
        • Almagro P.
        • Cabrera F.J.
        • Diez J.
        • et al.
        Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study.
        Chest. 2012; 142: 1126-1133
        • Antonelli Incalzi R.
        • Fuso L.
        • De Rosa M.
        • et al.
        Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease.
        Eur Respir J. 1997; 10: 2794-2800
        • Paz-Díaz H.
        • Montes de Oca M.
        • López J.M.
        • et al.
        Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD.
        Am J Phys Med Rehabil. 2007; 86: 30-36
        • Puente-Maestu L.
        • Palange P.
        • Casaburi R.
        • et al.
        Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.
        Eur Respir J. 2016; 47: 429-460
        • Celli B.
        • Tetzlaff K.
        • Criner G.
        • et al.
        The 6-minute-walk distance test as a chronic obstructive pulmonary disease stratification tool. Insights from the COPD biomarker qualification Consortium.
        Am J Respir Crit Care Med. 2016; 194: 1483-1493
        • Armstrong M.
        • Winnard A.
        • Chynkiamis N.
        • et al.
        Use of pedometers as a tool to promote daily physical activity levels in patients with COPD: a systematic review and meta-analysis.
        Eur Respir Rev. 2019; 28: 190039
        • Montes de Oca M.
        • Torres S.H.
        • Gonzalez Y.
        • et al.
        Peripheral muscle composition and health status in patients with COPD.
        Respir Med. 2006; 100: 1800-1806
        • Swallow E.B.
        • Reyes D.
        • Hopkinson N.S.
        • et al.
        Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease.
        Thorax. 2007; 62: 115-120
        • Gea J.G.
        • Pasto M.
        • Carmona M.A.
        • et al.
        Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease.
        Eur Respir J. 2001; 17: 939-945
        • Cote C.G.
        • Dordelly L.J.
        • Celli B.R.
        Impact of COPD exacerbations on patient-centered outcomes.
        Chest. 2015; 131: 696-704
        • Bui K.-L.
        • Nyberg A.
        • Rabinovich R.
        • et al.
        The relevance of limb muscle dysfunction in chronic obstructive pulmonary disease: a review for clinicians.
        Clin Chest Med. 2019; 40: 367-383
        • Abdulai R.M.
        • Jensen T.J.
        • Patel N.R.
        • et al.
        Deterioration of limb muscle function during acute exacerbation of chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2018; 197: 433-449
        • Sin D.D.
        • Wu L.
        • Man S.F.P.
        The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature.
        Chest. 2005; 127: 1952-1959
        • Padeletti M.
        • Jelic S.
        • LeJemtel T.H.
        Coexistent chronic obstructive pulmonary disease and heart failure in the elderly.
        Int J Cardiol. 2008; 125: 209-215
        • Barr R.G.
        • Bluemke D.A.
        • Ahmed F.S.
        • et al.
        Percent emphysema, airflow obstruction, and impaired left ventricular filling.
        N Engl J Med. 2010; 362: 217-227
        • Wells J.M.
        • Washko G.R.
        • Han M.K.
        • et al.
        Pulmonary arterial enlargement and acute exacerbations of COPD.
        N Engl J Med. 2012; 367: 913-921
        • de Torres J.P.
        • Ezponda A.
        • Alcaide A.B.
        • et al.
        Pulmonary arterial enlargement predicts long-term survival in COPD patients.
        PLoS One. 2018; 13 (e0195640–13)
        • O'Donnell D.E.
        • Elbehairy A.F.
        • Webb K.A.
        • et al.
        • Canadian Respiratory Research Network
        The link between reduced inspiratory capacity and exercise intolerance in chronic obstructive pulmonary disease.
        Ann Am Thorac Soc. 2017; 14: S30-S39
        • Butler J.
        • Schrijen F.
        • Henriquez A.
        • et al.
        Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease.
        Am Rev Respir Dis. 1988; 138: 350-354
        • Turner M.C.
        • Chen Y.
        • Krewski D.
        • et al.
        Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers.
        Am J Respir Crit Care Med. 2007; 176: 285-290
        • de Torres J.P.
        • Bastarrika G.
        • Wisnivesky J.P.
        • et al.
        Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest.
        Chest. 2007; 132: 1932-1938
        • de Koning H.J.
        • van der Aalst C.M.
        • de Jong P.A.
        • et al.
        Reduced lung-cancer mortality with volume CT screening in a randomized trial.
        N Engl J Med. 2020; 382: 503-513
        • Yohannes A.M.
        • Kaplan A.
        • Hanania N.A.
        Anxiety and depression in chronic obstructive pulmonary disease: recognition and management.
        Cleve Clin J Med. 2018; 85: S11-S18
        • Hill K.
        • Geist R.
        • Goldstein R.S.
        • et al.
        Anxiety and depression in end-stage COPD.
        Eur Respir J. 2008; 31: 667-677
        • Cully J.A.
        • Graham D.P.
        • Stanley M.A.
        • et al.
        Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression.
        Psychosomatics. 2006; 47: 312-319
        • Ng T.-P.
        • Niti M.
        • Tan W.-C.
        • et al.
        Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life.
        Arch Intern Med. 2006; 167: 60-67
        • Jørgensen N.R.
        • Schwarz P.
        Osteoporosis in chronic obstructive pulmonary disease patients.
        Curr Opin Pulm Med. 2008; 14: 122-127
        • Ebeling P.R.
        Clinical practice. Osteoporosis in men.
        N Engl J Med. 2008; 358: 1474-1482
        • Fabbri L.M.
        • Luppi F.
        • Beghe B.
        • et al.
        Complex chronic comorbidities of COPD.
        Eur Respir J. 2008; 31: 204-212
        • Marin J.M.
        • Soriano J.B.
        • Carrizo S.J.
        • et al.
        Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome.
        Am J Respir Crit Care Med. 2010; 182: 325-331
        • John M.
        • Lange A.
        • Hoernig S.
        • et al.
        Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases.
        Int J Cardiol. 2006; 111: 365-370
        • Cote C.
        • Zilberberg M.D.
        • Mody S.H.
        • et al.
        Haemoglobin level and its clinical impact in a cohort of patients with COPD.
        Eur Respir J. 2007; 29: 923-929
        • Boyd C.M.
        • Darer J.
        • Boult C.
        • et al.
        Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance.
        JAMA. 2005; 294: 716-724
        • Vanfleteren L.E.G.W.
        • Spruit M.A.
        • Wouters E.F.M.
        • et al.
        Management of chronic obstructive pulmonary disease beyond the lungs.
        Lancet Respir Med. 2016; 4: 911-924
        • Vanfleteren L.
        • Spruit M.A.
        • Franssen F.
        Tailoring the approach to multimorbidity in adults with respiratory disease: the NICE guideline.
        Eur Respir J. 2017; 49: 1601696
        • Fabbri L.M.
        • Boyd C.
        • Boschetto P.
        • et al.
        How to integrate multiple comorbidities in guideline development: article 10 in integrating and coordinating efforts in COPD guideline development. an official ATS/ERS Workshop Report.
        Proc Am Thorac Soc. 2012; 9: 274-281
        • Calverley P.M.A.
        • Anderson J.A.
        • Celli B.
        • et al.
        Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
        N Engl J Med. 2007; 356: 775-789
        • Vestbo J.
        • Anderson J.A.
        • Brook R.D.
        • et al.
        Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomized controlled trial.
        Lancet. 2016; 387: 1817-1826
      2. Mignot J. Strategic behavior in road cycling competitions. The Economics of Professional Road Cycling https://doi.org/10.1007/978-3-319-22312-4.

        • Ben-Shlomo Y.
        • Kuh D.
        A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives.
        Int J Epidemiol. 2002; 31: 285-293
        • Lange P.
        • Celli B.
        • Agusti A.
        • et al.
        Lung-function trajectories leading to chronic obstructive pulmonary disease.
        N Engl J Med. 2015; 373: 111-122
        • Jensen A.B.
        • Moseley P.L.
        • Oprea T.I.
        • et al.
        Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients.
        Nat Commun. 2014; 5: 1769
        • Wasswa-Kintu S.
        • Gan W.Q.
        • Man S.F.P.
        • et al.
        Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis.
        Thorax. 2005; 60: 570-575
        • de-Torres J.P.
        • Marin J.M.
        • Casanova C.
        • et al.
        Identification of COPD patients at high risk for lung cancer mortality using the COPD-LUCSS-DLCO.
        Chest. 2016; 149: 936-942
        • Divo M.J.
        • Casanova C.
        • Marin J.M.
        • et al.
        COPD comorbidities network.
        Eur Respir J. 2015; 46: 640-650
        • Rennard S.I.
        • Locantore N.
        • Delafont B.
        • et al.
        Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis.
        Ann Am Thorac Soc. 2015; 12: 303-312
        • Burgel P.R.
        • Paillasseur J.L.
        • Caillaud D.
        • et al.
        Clinical COPD phenotypes: a novel approach using principal component and cluster analyses.
        Eur Respir J. 2010; 36: 531-539
        • Burgel P.-R.
        • Paillasseur J.-L.
        • Janssens W.
        • et al.
        A simple algorithm for the identification of clinical COPD phenotypes.
        Eur Respir J. 2017; 50: 1701034
        • Garcia-Aymerich J.
        • Gómez F.P.
        • Benet M.
        • et al.
        Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.
        Thorax. 2011; 66: 430-437
        • Loscalzo J.
        • Kohane I.
        • Barabási A.-L.
        Human disease classification in the postgenomic era: a complex systems approach to human pathobiology.
        Mol Syst Biol. 2007; 3: 124
        • Celli B.R.
        • Locantore N.
        • Tal-Singer R.
        • et al.
        Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype.
        Eur Respir J. 2018; 51: 1702146
        • Dornhorst A.C.
        Respiratory insufficiency.
        Lancet. 1955; 268: 1185-1187